𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reply: Estimation of lead-time and overdiagnosis in breast cancer screening

✍ Scribed by Duffy, S W; Lynge, E; Jonsson, H

Book ID
109999905
Publisher
Nature Publishing Group
Year
2009
Tongue
English
Weight
41 KB
Volume
100
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Estimates of lead time and length bias i
Estimates of lead time and length bias in a breast cancer screening program
✍ Michael Shwartz πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 831 KB

Assume that the benefit of screening for breast cancer with a combination of mammography and a clinical examination is measured by comparing the five-year survival rate of women detected by screening to the five-year survival rate of women who surface clinically with breast cancer, e.g., to the surv

An Estimate of the Variance of Estimator
An Estimate of the Variance of Estimators for Lead Time and Screening Benefit Time in Randomized Cancer Screening Trials
✍ Karen Kafadar; Philip C. Prorok; Paul J. Smith πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 3 views

Variance estimators are derived for estimators of the average lead time and average benefit time due to screening in a randomized screening trial via influence functions. The influence functions demonstrate that these estimators are asymptotically equivalent to the mean difference, between the study